Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cesarean scar pregnancy uterine-preserving treatment trial
RBR-22hc4rmRecruiting
- Sponsor
- Escola Paulista de Medicina
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of methotrexate in cesarean scar pregnancy (CSEP) (2 arms), sponsored by Escola Paulista de Medicina. Started Jan 2023; status: recruiting.
02
Drugs
methotrexate
03
Conditions
cesarean scar pregnancy (CSEP)
Beyond the preview
Go deeper on RBR-22hc4rm.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-22hc4rm.